Brief: Eurofins Scientific Achieves Organic Growth Of 2.6% In Q1
22/04/2026 06:22
April 22 (Reuters) - Eurofins Scientific SE EUFI.PA: EUROFINS ACHIEVES ORGANIC GROWTH OF 2.6% IN Q1 2026, INCLUDING IMPACT OF EXCEPTIONALLY SEVERE WEATHER; 2026 AND MID-TERM OBJECTIVES REITERATED Q1 2026 REVENUE RISES 1.3% TO €1,789M Q1 2026 ORGANIC GROWTH IN EUROPE 1.7% REITERATES OBJECTIVES FOR FY 2026, MID-TERM, AND FY 2027 CONFIRMS LONG-TERM ORGANIC GROWTH OBJECTIVE OF 6.5% PER ANNUM REMAIN CONFIDENT IN FUNDAMENTAL STRENGTH OF BIOPHARMA PORTFOLIO REPURCHASING SHARES FOR EUR 110 MILLION DURING Q1 OF 2026 Source text: ID:nNDL361d75 Further company coverage: EUFI.PA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))